The Goldman Sachs Group Boosts Bruker (NASDAQ:BRKR) Price Ta

Bruker (NASDAQ:BRKR – Get Free Report) had its price target upped by The Goldman Sachs Group from $66.00 to $74.00 in a research note issued on Wednesday, Benzinga reports. The brokerage currently has a “sell” rating on the medical research company’s stock. The Goldman Sachs Group’s target price would suggest a potential downside of 16.58% […]

Related Keywords

United States , Hermann Fritz Requardt , Asia Pacific , Stifel Nicolaus , Bruker Corporation , Lindbrook Capital , Townsquare Capital , Wells Fargo Company , Bruker Energy Supercon Technologies , Baker Tilly Wealth Management , Securities Exchange Commission , Jpmorgan Chase Co , Wolfe Research , Goldman Sachs Group , First Republic Investment Management Inc , Get Free Report , Trading Down , Director Hermann Fritz Requardt , Exchange Commission , Republic Investment Management , Tilly Wealth Management , Farther Finance Advisors , Finance Advisors , Bruker Scientific Instruments , Bruker Energy , Bruker Daily , Bruker , Nasdaq Brkr , Brkr , Computer And Technology , 11679410 , Boost Price Target , The Goldman Sachs Group Inc ,